Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ CIITA Antibody Blocking Peptide
SDP

Catalog No. NBP259072PP Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP259072PP 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP259072PP Supplier Novus Biologicals™ Supplier No. NBP259072PEP
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

16 amino acids near the amino terminus of human CIITA. Source: Synthetic (Accession #: P33076) The CIITA Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 4261
Protein Family CIITA
Common Name CIITA Blocking Peptide
Concentration 0.2 mg/mL
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) Antibody Competition
Gene Alias C2TA, C2TAMHC class II transactivator type III, CIITAIV, class II, major histocompatibility complex, transactivator, MHC class II transactivator, MHC2TANLR family, acid domain containing, NLRA, nucleotide-binding oligomerization domain, leucine rich repea
Gene Symbol CIITA
Label Type Unlabeled
Product Type Recombinant Protein
Quantity 0.05 mg
Regulatory Status RUO
Source Synthetic
Show More Show Less

For Research Use Only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.